Carter Paul Rutherford

Of the 44 filings by Carter Paul Rutherford, 31 date from 2016, the year when Gilead Sciences, Inc. (title: EVP Commercial Ops) concentrated the activity. The trades run from January 4, 2016 to October 20, 2024, and Gilead Sciences, Inc. holds 31 filings in all, HUTCHMED (China) Ltd. 8 and Mallinckrodt plc 5, the last two as a Director.

One sale dominates: EUR 4,452,630 on May 31, 2016 at Gilead Sciences, Inc. The others are much smaller, such as EUR 182,790 on January 4, 2016 and EUR 161,448 on March 1, 2016. The 9 sales weigh EUR 5.7 million, median EUR 155,545. One purchase is recorded, with no amount in the data. There are also 17 option exercises, 9 grants and 8 other filings.

After 2016 the pace falls to 1 to 3 filings a year through 2024. No filing sits in the last twelve months.

Trades by Rutherford within 30 days of colleagues at Gilead Sciences, Inc. number 9, 8 and 3. All in the same direction. Names in order: John C. Martin, John F. Milligan and Gregg H. Alton. Publication takes a median of 2 days.